Work

Prognostic factors in resectable pancreatic cancer: p53 and Bcl-2

Year: 1999

Type: article

Study design: Observational Study

Source: Journal of Gastrointestinal Surgery

DOI: 10.1016/s1091-255x(99)80068-7

Authors: Richard J. Bold, Kenneth R. Hess, A. Scott Pearson, Ana M. Grau, Frank A. Sinicrope, Mary Jennings, David J. McConkey, Corazon D. Bucana, Karen R. Cleary, Pamela A. Hallin, Paul J. Chiao, James L. Abbruzzese, Douglas B. Evans

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G2624822249, BASIS OF ANTIANGIOGENESIS THERAPY IN PANCREATIC CANCER

OpenAlex ID: W2165824393

FWCI: 1.101

Cites: 54

Cited by: 48

Related to: 10